Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression

NACompletedINTERVENTIONAL
Enrollment

219

Participants

Timeline

Start Date

June 26, 2018

Primary Completion Date

November 22, 2024

Study Completion Date

November 22, 2024

Conditions
DepressionUnipolar DepressionTreatment Resistant Depression
Interventions
DEVICE

Magnetic Seizure Therapy

"MST treatment will be administered using the MagPro MST with a Cool TwinCoil over the frontal cortex in the midline position using 100 Hz stimulation. The MST determination of seizure threshold will be done using 100% machine output applied at 100 Hz at progressively escalating train durations, commencing at 2 seconds and increasing by 2 seconds with each subsequent stimulation until an adequate seizure is produced. During subsequent sessions, one stimulation will be delivered using a train duration that is 4 seconds longer than the train duration at threshold (with a maximum train duration of 10 seconds).~This will be performed under the effect of anesthesia. The treatment procedure is approximately 10 minutes, followed by a recovery period of approximately 30 minutes."

DEVICE

Electroconvulsive Therapy

In the ECT arm treatment, the MECTA spectrum 5000Q or the MECTA Sigma devices will be used, which are FDA approved devices used for providing standard-of-care clinical ECT treatments. The ECT determination of seizure threshold and the adjustment of energy at subsequent sessions will be based on a standard published protocol. All participants will receive RUL-UB ECT at six times the seizure threshold under the effect of anesthesia. The treatment procedure is approximately 10 minutes, followed by a recovery period of approximately 30 minutes

Trial Locations (3)

92127

University of California San Diego, San Diego

75390-9127

University of Texas Southwestern Medical Center, Dallas

M6J 1H4

Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

collaborator

Centre for Addiction and Mental Health

OTHER

collaborator

University of California, San Diego

OTHER

lead

University of Texas Southwestern Medical Center

OTHER

NCT03191058 - Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression | Biotech Hunter | Biotech Hunter